4
MARKET OVERVIEW
Highlights the market structure, growth drivers, restraints, and near-term inflection points influencing performance.
4.2
UNMET NEEDS AND WHITE SPACES
4.3
INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
4.4
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
5
INDUSTRY TRENDS
Provides a snapshot of current market scenario, value chain context, and factors impacting competitive intensity.
5.1
PORTER’S FIVE FORCES ANALYSIS
5.1.1
THREAT OF NEW ENTRANTS
5.1.2
BARGAINING POWER OF SUPPLIERS
5.1.3
BARGAINING POWER OF BUYERS
5.1.4
THREAT OF SUBSTITUTES
5.1.5
INTENSITY OF COMPETITIVE RIVALRY
5.2
MACROECONOMICS INDICATORS
5.2.2
GDP TRENDS AND FORECAST
5.2.3
TRENDS IN ASIA-PACIFIC CONTRAST MEDIA MARKET
5.4
SUPPLY CHAIN ANALYSIS
5.6.1
AVERAGE SELLING PRICE TRENDS, BY KEY PLAYERS (2023-2025
5.6.2
AVERAGE SELLING PRICE TRENDS, BY PRODUCT TYPE (2023-2025)
5.8
KEY CONFERENCES & EVENTS IN 2025-2026
5.9
TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESS
5.10
INVESTMENT AND FUNDING SCENARIO
5.12
IMPACT OF 2025 US TARIFF: ASIA-PACIFIC CONTRAST MEDIA MARKET
5.12.3
PRICE IMPACT ANALYSIS
5.12.5
IMPACT OF END USE INDUSTRIES
6
STRATEGIC DISRUPTION THROUGH TECHNOLOGY, PATENTS, DIGITAL, AND AI ADOPTIONS
6.1
KEY EMERGING TECHNOLOGIES
6.2
COMPLEMENTARY TECHNOLOGIES
6.3
TECHNOLOGY/PRODUCT ROADMAP
6.5
IMPACT OF AI/GEN AI ON THE ASIA-PACIFIC CONTRAST MEDIA MARKET
6.5.1
TOP USE CASES AND MARKET POTENTIAL
6.5.2
BEST PRACTICES IN ASIA-PACIFIC CONTRAST MEDIA
6.5.3
CASE STUDIES OF AI IMPLEMENTATION IN ASIA-PACIFIC CONTRAST MEDIA MARKET
6.5.4
INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
6.5.5
CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN ASIA-PACIFIC CONTRAST MEDIA MARKET
6.6
SUCCESS STORIES AND REAL-WORLD APPLICATIONS
7.1
COUNTRY REGULATIONS AND COMPLIANCE
7.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
7.1.2
REGULATORY LANDSCAPE
8
CUSTOMER LANDSCAPE & BUYER BEHAVIOR
8.1
DECISION-MAKING PROCESS
8.2
BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
8.3
ADOPTION BARRIERS & INTERNAL CHALLENGES
8.4
UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
9
ASIA-PACIFIC CONTRAST MEDIA MARKET DATA, BY TYPE (MARKET SIZE & FORECAST TO 2031-IN VALUE, USD MILLION)
COMPARATIVE ASSESSMENT OF KEY TYPE SUB-CATEGORIES, THEIR MARKET POTENTIAL, AND DEMAND PATTERNS AT THE REGIONAL AND COUNTRY LEVEL
9.1
IODINATED CONTRAST MEDIA
9.2
GADOLINIUM-BASED CONTRAST MEDIA
9.3
MICROBUBBLE CONTRAST MEDIA
9.4
BARIUM-BASED CONTRAST MEDIA
10
ASIA-PACIFIC CONTRAST MEDIA MARKET DATA, BY FORM (MARKET SIZE & FORECAST TO 2031 – IN VALUE, USD MILLION)
COMPARATIVE ASSESSMENT OF KEY FORM, THEIR MARKET POTENTIAL, AND DEMAND PATTERNS AT THE REGIONAL AND COUNTRY LEVEL
11
ASIA-PACIFIC CONTRAST MEDIA MARKET DATA, BY MODALITY (MARKET SIZE & FORECAST TO 2031 – IN VALUE, USD MILLION)
COMPARATIVE ASSESSMENT OF KEY SYSTEM, THEIR MARKET POTENTIAL, AND DEMAND PATTERNS AT THE REGIONAL AND COUNTRY LEVEL
12
ASIA-PACIFIC CONTRAST MEDIA DATA, BY ROUTE OF ADMINISTRATION (MARKET SIZE & FORECAST TO 2031 – IN VALUE, USD MILLION)
COMPARATIVE ASSESSMENT OF KEY PORTABILITY, THEIR MARKET POTENTIAL, AND DEMAND PATTERNS AT THE REGIONAL AND COUNTRY LEVEL
12.1.1
INTRAVENOUS (IV) ROUTE
12.1.2
INTRA-ARTERIAL (IA) ROUTE
13
ASIA-PACIFIC CONTRAST MEDIA MARKET, BY INDICATION (MARKET SIZE & FORECAST TO 2031 – IN VALUE, USD MILLION)
COUNTRY-SPECIFIC ADOPTION DRIVERS, DEMAND DYNAMIC, AND MARKET POTENTIAL ACROSS EACH ADMINISTRATION SEGMENT
13.1
CARDIOVASCULAR DISEASE
13.3
GASTROINTESTINAL DISORDERS
13.4
MUSCULOSKELETAL DISORDERS
13.5
NEUROLOGICAL DISORDERS
13.6
NEPHROLOGICAL DISORDERS
14
ASIA-PACIFIC CONTRAST MEDIA MARKET DATA, BY APPLICATION (MARKET SIZE & FORECAST TO 2031 – IN VALUE, USD MILLION)
COMPARATIVE ASSESSMENT OF KEY SYSTEMS, THEIR MARKET POTENTIAL, AND DEMAND PATTERNS AT THE REGIONAL AND COUNTRY LEVEL
14.2
INTERVENTIONAL RADIOLOGY
14.3
INTERVENTIONAL CARDIOLOGY
15
ASIA-PACIFIC CONTRAST MEDIA MARKET DATA, BY ENS-USER (MARKET SIZE & FORECAST TO 2031 – IN VALUE, USD MILLION)
COUNTRY-SPECIFIC ADOPTION DRIVERS, DEMAND DYNAMICS, AND MARKET POTENTIAL ACROSS EACH END-USER SEGMENT
15.1
HOSPITALS, CLINICS, & AMBULATORY SURGERY CENTERS
15.2
DIAGNOSTIC IMAGING CENTERS
16
ASIA-PACIFIC CONTRAST MEDIA MARKET DATA, BY COUNTRY (MARKET SIZE & FORECAST TO 2031 – IN VALUE, USD MILLION)
ASSESSING GROWTH PATTERNS, INDUSTRY FORCES, REGULATORY LANDSCAPE, AND MARKET POTENTIAL ACROSS KEY COUNTRIES
16.7
REST OF ASIA-PACIFIC
STRATEGIC ASSESSMENT OF LEADING PLAYERS, MARKET SHARE, COMPANY POSITIONING, AND COMPETITIVE BENCHMARKS INFLUENCING MARKET POTENTIAL
17.2
KEY PLAYER STRATEGIES/RIGHT TO WIN (2021-2024)
17.3
REVENUE ANALYSIS (2021-2024)
17.4
MARKET SHARE ANALYSIS BY KEY PLAYERS,
17.5
COMPANY EVALUATION MATRIX: KEY PLAYERS,
17.5.5
COMPANY FOOTPRINT: KEY PLAYERS,
17.5.5.1
COMPANY FOOTPRINT
17.5.5.2
COUNTRY FOOTPRINT
17.5.5.5
MODALITY FOOTPRINT
17.5.5.6
ROUTE OF ADMINISTRATION FOOTPRINT
17.5.5.7
INDICATION FOOTPRINT
17.5.5.8
APPLICATION FOOTPRINT
17.5.5.9
END-USER FOOTPRINT
17.6
COMPANY EVALUATION MATRIX: STARTUPS/SMES,
17.6.1
PROGRESSIVE COMPANIES
17.6.2
RESPONSIVE COMPANIES
17.6.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES,
17.6.5.1
DETAILED LIST OF KEY STARTUPS/SMES
17.6.5.2
COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
17.7
COMPETITIVE SCENARIO AND TRENDS (2021-2025)
17.7.1
NEW PRODUCT LAUNCHES & APPROVALS
17.7.3
OTHER DEVELOPMENTS
17.8
BRAND/PRODUCT COMPARATIVE ANALYSIS PRODUCT COMPARISON
17.9
COMPANY VALUATION AND FINANCIAL METRICS
IN-DEPTH REVIEW OF COMPANIES, PRODUCTS, SERVICES, RECENT INITIATIVES, AND POSITIONING STRATEGIES IN THE ASIA-PACIFIC DIGITAL X-RAY MARKET LANDSCAPE
18.1.2
BRACCO IMAGING S.P.A.
18.1.5
LANTHEUS MEDICAL IMAGING
18.1.6
UNIJULES LIFE SCIENCES LTD.
18.1.7
J.B CHEMICALS & PHARMACEUTICALS LIMITED
18.1.8
SANOCHEMIA PHARMAZEUTIKA
18.1.11
IMAX DIAGNOSTIC IMAGING LTD.
18.1.12
YANGTZE RIVER PHARMACEUTICAL GROUP
18.1.13
LIVEALTH BIOPHARMA PVT. LTD.
18.1.14
BEIJING BEILU PHARMACEUTICAL
18.1.15
UNISPIRE BIOPHARMA PRIVATE LIMITED
18.2.1
ARCO LIFESCIENCES PVT LTD
18.2.2
STANEX DRUGS & CHEMICALS PVT. LTD.
18.2.4
SUBHRA PHARMA PRIVATE LIMITED
18.2.6
FUJIFILM WAKO PURE CHEMICAL CORPORATION
18.2.7
TRIVITRON HEALTHCARE
18.2.8
REGE IMAGING & CINE FILMS PRIVATE LIMITED
18.2.9
JIANGSU HENGRUI MEDICINE
18.2.10
SINO MEDICAL-DEVICE TECHNOLOGY CO., LTD.
19.1
RESEARCH DATA SOURCES
19.1.1
SECONDARY RESEARCH
19.1.2.2
KEY INDUSTRY INSIGHTS
19.1.2.3
BREAKDOWN OF PRIMARIES
19.2
MARKET SIZE ESTIMATION METHODOLOGY
19.2.1
REVENUE-MAPPING BASED MARKET ESTIMATION
19.2.2
END-USER BASED MARKET ESTIMATION
19.3
MARKET FORECASTING APPROACH
19.4
MARKET BREAKDOWN AND DATA TRIANGULATION
19.5
RESEARCH ASSUMPTIONS
19.6
RESEARCH LIMITATIONS
19.6.1
SCOPE-RELATED LIMITATIONS
19.6.2
METHODOLOGY RELATED LIMITATIONS
Growth opportunities and latent adjacency in Asia-Pacific Contrast Media Market